Form F-X - Appointment of Agent for Service of Process and Undertaking
June 14 2024 - 5:23PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM F-X
Appointment of Agent For Service of Process
And Undertaking
A. Name of issuer or person filing (the “Filer”): |
|
Profound Medical Corp. |
B.
(1) This is (check one):
x an
original filing for the Filer
¨ an
amended filing for the Filer
(2)
Check the following box if you are filing the Form F-X in paper in accordance with Regulation S-T Rule 101(b)(9) ¨
C.
Identify the filing in conjunction with which this form is being filed:
Name
of Registrant: |
|
Profound Medical Corp.
|
|
|
|
Form
Type: |
|
Registration Statement
on Form F-10 |
|
|
|
File
Number (if known): |
|
333-280236 |
|
|
|
Filed
by: |
|
Profound Medical Corp.
|
|
|
|
Date
Filed (if filed concurrently, so indicate): |
|
June 14, 2024 (filed
concurrently) |
D.
Filer is incorporated or organized under the laws of Ontario, Canada and has its principal place of business at:
2400 Skymark Avenue,
Unit 6,
Mississauga, Ontario, Canada
L4W 5K5
(telephone:
(647) 476-1350).
E.
The Filer designates and appoints Profound Medical (U.S.) Inc. (the “Agent”), located at
9160 Forum Corporate Parkway,
Suite 359
Fort Myers, FL
33905
(telephone: (647) 476-1350)
Attention: Arun Menawat
as the agent of the Filer upon whom may be served
any process, pleadings, subpoenas, or other papers in:
(a) any investigation or administrative proceeding conducted
by the Commission; and
(b) any civil suit or action brought against the Filer or
to which the Filer has been joined as defendant or respondent, in any appropriate court in any place subject to the jurisdiction of any
state or of the United States or of any of its territories or possessions or of the District of Columbia, where the investigation, proceeding
or cause of action arises out of or relates to or concerns any offering made or purported to be made in connection with the securities
registered or qualified by the Filer on Form F-10 on the date hereof (the “Form F-10”) or any purchases or sales of any security
in connection therewith. The Filer stipulates and agrees that any such civil suit or action or administrative proceeding may be commenced
by the service of process upon, and that service of an administrative subpoena shall be effected by service upon such agent for service
of process, and that the service as aforesaid shall be taken and held in all courts and administrative tribunals to be valid and binding
as if personal service thereof had been made.
|
F. |
The Filer stipulates and agrees to appoint a successor agent for service of process and file an amended Form F-X if the Filer discharges the Agent or the Agent is unwilling or unable to accept service on behalf of the Filer at any time until six years have elapsed from the date the issuer of the securities to which such forms and schedules relate has ceased reporting under the Exchange Act. |
The Filer further undertakes to advise the Commission promptly
of any change to the Agent’s name or address during the applicable period by amendment of this form, referencing the file number
of the relevant form in conjunction with which the amendment is being filed.
|
G. |
The Filer undertakes to make available, in person or by telephone, representatives to respond to inquiries made by the Commission staff, and to furnish promptly, when requested to do so by the Commission staff, information relating to the Form F-10; the securities to which the Form F-10 relates; and the transactions in such securities. |
The Filer certifies that it has duly caused this
power of attorney, consent, stipulation and agreement to be signed on its behalf by the undersigned, thereto duly authorized, in the City
of Mississauga, Province of Ontario, Country of Canada, on June 14, 2024.
Filer: |
PROFOUND MEDICAL CORP. |
|
|
|
|
|
|
|
|
|
|
By: |
/s/
Rashed Dewan |
|
|
|
Name: |
Rashed Dewan |
|
|
|
Title: |
Chief Financial Officer |
|
This statement has been signed by the following
person in the capacity and on the date indicated:
PROFOUND MEDICAL (U.S.) INC. |
|
|
|
as U.S. agent for service of process |
|
|
|
|
By: |
/s/
Arun Menawat |
|
|
Name: |
Arun Menawat |
|
|
Title: |
Chief Executive Officer |
|
Profound Medical (NASDAQ:PROF)
Historical Stock Chart
From Jul 2024 to Aug 2024
Profound Medical (NASDAQ:PROF)
Historical Stock Chart
From Aug 2023 to Aug 2024